ADMA Biologics, Inc. (ADMA)

17.87 -0.37 (-2.03%) USD  |  NASDAQ  |  Jan 02, 11:48
More

ADMA Biologics Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Arcutis Biotherapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade